Here’s how 3D printing could help fight this aggressive type of cancer

3D printing fights cancer
(Image credit: BCN3D)

A 3D printer has been used to isolate stem cells from one of the most aggressive types of breast cancer, in a bid to develop a drug which can help in the fight against that particular cancer.

This breakthrough comes from a team of researchers at the University of Girona in Spain, who employed the BCN3D Sigma 3D printer in order to make three-dimensional scaffolds which replicate the structures found in human tissues.

The aforementioned triple negative breast cancer – which affects young women – is highly aggressive and even after treatment using chemotherapy or radiotherapy, tumor cells still remain in the body.

As a result, one of the most dangerous facets of this cancer is its high relapse rate, and the idea is the 3D scaffolds are used to separate the stem cells which are responsible for causing those relapses so that they can be studied in the laboratory.

And the hope is that could lead to the development of a drug which can exclusively attack those cells, without damaging other parts of the body, therefore avoiding the danger of a relapse after treatment.


Dr Teresa Puig, one of the researchers involved in the project, noted that with triple negative breast cancer, relapses happen with 20% to 30% of patients, and they occur within three to four years.

Before the 3D printing technology became involved, the researchers had been producing cell cultures two-dimensionally, but this technique didn’t allow the cells to be effectively separated.

Now that isolation can be achieved, close investigation of the stem cells will hopefully find the bio-indicators responsible for the tumors, and a suitable drug along the aforementioned lines can then be developed.

Darren is a freelancer writing news and features for TechRadar (and occasionally T3) across a broad range of computing topics including CPUs, GPUs, various other hardware, VPNs, antivirus and more. He has written about tech for the best part of three decades, and writes books in his spare time (his debut novel - 'I Know What You Did Last Supper' - was published by Hachette UK in 2013).